Title: Xu J, et al. Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. Clin Pharmacol Drug Dev. 2014 May;3(3):170-8.
56100-41-5 | d-Atabrine dihydrochloride | AA01EOP5 | MFCD31630800
1445751-74-5 | (1-(1-methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | AA01EOWU | MFCD30718186
1329805-78-8 | 6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol-d9 | AA01EP6N
1877243-60-1 | N-[[1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl]carbonyl]-L-valine | AA01EPFJ
1776115-10-6 | 9-[4-[(2-bromophenyl)methoxy]phenyl]-3,4,5,6,7,9-hexahydro-3,3,6,6-tetramethyl-1H-xanthene-1,8(2H)-dione | AA01EPKN
79353-39-2 | 3-(8Z,11Z)-8,11,14-pentadecatrien-1-yl-phenol | AA01EPRC
35299-94-6 | 2-amino-1-hydroxy-3-octadecanone,monohydrochloride | AA01EPYQ
171347-75-4 | (3R)-3-[[[(1S)-1-(1H-indol-3-ylmethyl)-2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]amino]carbonyl]-5-methyl-hexanoicacid | AA01EQ71
1798328-24-1 | TD52 | AA01EQCV | MFCD31697737
116599-47-4 | 1-(2-Hydroxycyclohexyl)pyridinium perchlorate | AA01EQRI | MFCD00956671